Numaferm
D├╝sseldorf
About Numaferm
NUMAFERM challenges this paradigm. We have developed a reliable, cost-efficient manufacturing process that enables the reduction of production costs dramatically (up to 1000x). How is it possible? Our process is based on a well-designed microorganism that converts simple nutrients to peptides. It is the first-in-place bioprocess that serves as a reliable platform for the production of peptides; independent of their sequence, length or functionality.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $81.4K
- Funding stage: Seed
- Last round: Grant (Nov 2018)
- Website: numaferm.com
- Phone: +4921197532901
Industries & Categories
Biotechnology, Manufacturing, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/numaferm-188307 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.